medicalxpress - The U.S. Food and Drug Administration (FDA) has approved bemotrizinol (BEMT) for use in over-the-counter sunscreen products.
AI Summary: The FDA approved a new sunscreen ingredient, the first addition to the U.S. roster in twenty years, opening the door to revamped formulations and potentially better sun protection. Regulators framed the move as modernizing dermatologic options and bolstering consumer confidence, while manufacturers eye reformulation and marketing opportunities.
FDA commissioner Marty Makary resigns amid mounting scrutiny / 4 wks
FDA Abortion Pill Decisions Rooted in Science / 4 months
FDA loosens data restrictions to accelerate drug reviews / 5 months
FDA Appoints Richard Pazdur to Lead Drug Division Amid Regulatory Shifts / 7 months
FDA links eight deaths to Amgen’s Tavneos; scrutiny intensifies / 2 months
FDA approves leucovorin for rare folate disorder despite autism hype / 2 months
FDA launches individualized therapy framework for ultra-rare diseases / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.